Brain development, brain functioning, growth and metabolic aspects in the clinical management of transsexual adolescents
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Transsexuality
- Sponsor
- Vrije University Medical Centre (VUMC) (The Netherlands)
- Enrollment
- 264
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
Abstract results in http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17074986 2017 Results article in https://pubmed.ncbi.nlm.nih.gov/28419243/ (added 06/08/2021) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32909025/ (added 06/08/2021) 2013 Results article in https://pubmed.ncbi.nlm.nih.gov/23433223/ (added 06/08/2021) 2015 Results article in https://pubmed.ncbi.nlm.nih.gov/25720349/ (added 06/08/2021) 2016 Results article in https://pubmed.ncbi.nlm.nih.gov/27318023/ (added 06/08/2021)
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria \- pubertal patients:
- •1\. Girls and boys with transsexualism who are eligible for sex reassignment according to psychologist and psychiatrist (if they are older than 12 years, psychologically stable and live in a stable social environment)
- •2\. Girls have to be in stage B2 and boys in G2\-G3 with measurable oestradiol and testosterone levels respectively
- •Inclusion criteria \- pre\-pubertal patients:
- •1\. Girls and boys with high probability of transsexualism according to psychologist or psychiatrist and the age of 9 to 12 years
- •2\. Girls have to be in an earlier stage than B2 and boys in an earlier stage than G2\-G3
- •Inclusion criteria \- healthy subjects:
- •1\. Girls and boys who are similar aged friends of the transsexual patients
Exclusion Criteria
- •Exclusion criteria \- patients:
- •1\. Intersex conditions
- •Exclusion criteria \- healthy subjects:
- •1\. Puberty delaying treatment or hormonal therapy; oral anticonception users are not excluded
Outcomes
Primary Outcomes
Not specified